Finance

Beta
Lists
NXG:CVE
NexgenRx Inc
CA$0.42
+2.44%
(+0.0100) 1D
May 29, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NXG...
Open
CA$0.42
High
CA$0.42
Low
CA$0.42
Mkt. cap
29.87M
Avg. vol.
58.82K
Volume
101.00K
Dividend
2.38%
Quarterly dividend
CA$0.00
Ex-dividend date
Apr 24, 2026
P/E ratio
19.18
52-wk high
CA$0.46
52-wk low
CA$0.28
EPS
CA$0.02
Beta
0.79
Shares outstanding
71.12M
No. of employees
20
Open
CA$0.42
High
CA$0.42
Low
CA$0.42
Mkt. cap
29.87M
Avg. vol.
58.82K
Volume
101.00K
Dividend
2.38%
Quarterly dividend
CA$0.00
Ex-dividend date
Apr 24, 2026
P/E ratio
19.18
52-wk high
CA$0.46
52-wk low
CA$0.28
EPS
CA$0.02
Beta
0.79
Shares outstanding
71.12M
No. of employees
20
News stories
From sources across the web
About NexgenRx Inc
CEO-
Employees20
Founded2003
HeadquartersToronto, Ontario, Canada
SectorInsurance
Websitenexgenrx.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.35M
4.62M
4.42M
5.00M
Cost of goods sold
785.48K
765.82K
520.55K
744.85K
Cost of revenue
785.48K
765.82K
520.55K
744.85K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.90M
2.93M
2.89M
2.77M
Operating expense
3.22M
3.24M
3.16M
3.00M
Total operating expenses
4.01M
4.01M
3.68M
3.75M
Operating income
338.93K
609.09K
734.96K
1.25M
Other non operating income
-35.70K
-35.66K
-37.72K
-37.74K
EBT including unusual items
330.66K
566.92K
533.63K
1.21M
EBT excluding unusual items
295.57K
566.92K
692.69K
1.21M
Income tax expense
-22.86K
-22.86K
714.41K
-22.86K
Effective tax rate
-6.91%
-4.03%
133.88%
-1.90%
Other operating expenses
-
-
-
-
Net income
353.52K
589.78K
-180.78K
1.23M
Net profit margin
8.13%
12.78%
-4.09%
24.58%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-7.65K
-6.50K
-4.55K
-5.61K
Net interest expenses
-7.65K
-6.50K
-4.55K
-5.61K
Depreciation and amortization charges
72.37K
61.14K
46.72K
56.45K
EBITDA
661.83K
922.43K
790.08K
1.30M
Gain or loss from assets sale
-35.09K
-
-2.33K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer